February 23, 2021
2 min read
Disclosures: Glatt reports no relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ADDED TO EMAIL ALERTS
We were unable to process your request. Please try again later. If you continue to have this issue please contact email@example.com.
Back to Healio
The fast and successful development of COVID-19 vaccines has generated hope for new and effective vaccines for other infectious diseases, including influenza.
Moderna, which developed one of the first two COVID-19 vaccines authorized in the United States, announced in January that it was expanding its messenger RNA vaccine portfolio to develop vaccine candidates against HIV, Nipah virus and seasonal influenza.
Scientists have long sought not only better seasonal influenza vaccines, but also a universal influenza vaccine that could offer protection against all strains of the virus for more than just one season — and perhaps even a lifetime…